SELLAS Life Sciences (SLS) Return on Sales (2013 - 2022)
SELLAS Life Sciences (SLS) posted quarterly Return on Sales of 0.42% for Q4 2022, down 39.0% year-over-year from 0.7% in Q4 2021, and up 4.66% quarter-over-quarter from 0.45% in Q3 2022.
SELLAS Life Sciences (SLS) Return on Sales (2013 - 2022) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Return on Sales for 6 consecutive years, with 0.42% the latest figure, recorded in Q4 2022.
- In Q4 2022, Return on Sales fell 39.0% year-over-year to 0.42%; the TTM figure through Dec 2022 stood at 0.42% (down 39.0% YoY), while the FY2022 annual figure was 0.41%, down 39.0% from the prior year.
- Return on Sales improved to 0.42% in Q4 2022 per SLS's latest filing, from 0.45% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q1 2021 and bottomed at 0.45% in Q3 2022.
- Historically, Return on Sales has averaged 0.14% across 3 years, with a median of 0.03% in 2021.
- Annual changes were most pronounced in 2021 — Return on Sales rose 2 bps — and 2022, when it sank 43 bps.
- SELLAS Life Sciences' Return on Sales stood at 0.02% in 2020, then sank by 51 bps to 0.03% in 2021, then plunged by 1156 bps to 0.42% in 2022.
- Business Quant data shows SLS's Return on Sales at 0.42% in Q4 2022, 0.45% in Q3 2022, and 0.44% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -0.42% |
| Sep 30, 2022 | -0.45% |
| Jun 30, 2022 | -0.44% |
| Mar 31, 2022 | -0.17% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2021 | -0.02% |
| Jun 30, 2021 | -0.02% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -0.02% |
| Sep 30, 2020 | -0.04% |
| Jun 30, 2020 | -0.01% |
| Mar 31, 2020 | 0.00% |
| Jun 30, 2015 | -0.01% |
| Mar 31, 2015 | -0.01% |
| Dec 31, 2014 | -0.01% |
| Sep 30, 2014 | -0.02% |
| Jun 30, 2014 | -0.09% |
| Mar 31, 2014 | -0.07% |
| Dec 31, 2013 | -0.02% |
| Sep 30, 2013 | -0.04% |